Human Immunodeficiency Virus Serology

Size: px
Start display at page:

Download "Human Immunodeficiency Virus Serology"

Transcription

1 Participant No: _ Human Immunodeficiency Virus Serology Survey No: RT :20 Please print the document labelled Clinical Notes & Test Instructions and enter your results via myqap. Kit Information Please supply kit lot number and expiry date (Please write expiry date as Mmm/yy example, Nov 19) If you have changed kits since the last RCPAQAP Serology survey, OR have not previously supplied your kit details to the RCPAQAP Serology, please provide us with your new kit details Test Results Units for example, S/CO Cut-off value is the absolute value that designates the cut-off point below which is negative or equivocal, and above or equal to is low positive or positive. Do not use >,,, < for cut-off value. Enter N/A (not applicable) if any of the above do not relate to your test for example, a latex agglutination test HIV Ag/ Ab Combination Testing HIV Ag/Ab Combination (Screening Assay) No. Value Ab Value Ag Circle test result Cut-off: (do not use >,,, Units: <) HIV Ag/Ab Combination No. Value Ab Value Ag Circle test result Cut-off: (do not use >,,, Units: <) If your kit provides a combined result value for HIV antigen and HIV antibody, please enter this value at BOTH the Value Ab and Value Ag result entry fields. HIV Antibody 1 & 2 ONLY Testing HIV Antibody 1 & 2 ONLY (Screening Assay) HIV Antibody 1 & 2 ONLY No. Value Circle test result No. Value Circle test result Cut-off: (do not use >,,, <) Units: Cut-off: (do not use >,,, <) Units: RS17-HIV Page 1 of 5

2 HIV Antibody 2 ONLY Testing HIV Antibody 2 ONLY No. Value Circle test result Cut-off: (do not use >,,, <) Units: HIV Antigen ONLY Testing HIV Antigen ONLY HIV Antigen ONLY No. Value Circle test result No. Value Circle test result Cut-off: (do not use >,,, <) Units: Cut-off: (do not use >,,, <) Units: RS17-HIV Page 2 of 5

3 HIV Antibody Confirmatory Testing HIV 1/2 Antibody Please NOTE Result options: neg (negative), pos (positive), HIV-1 Pos, HIV-2 Pos, ind (indeterminate), ind+hiv-2, insuff (insufficient), HIV-2 indicated or not tested. BioRad Geenius HIV gp41 p24 gp160 p31 gp140 gp36 MP Biomedicals BLOT gp160 gp120 p66 p55 p51 gp41 p39 p31 p24 p17 HIV-2 Fujirebio Inno-LIA HIV sgp120 gp41 p31 p24 p17 sgp105 gp36 RS17-HIV Page 3 of 5

4 HIV Antibody Confirmatory Testing (continued) HIV 1 Only Antibody BioRad New LAV HIV-1 gp160 gp110/120 p68/66 p55 p52/51 gp41 p40 p34/31 p24/25 p18/17 MP Biomedicals BLOT gp160 gp120 p66 p55 p51 gp41 p39 p31 p24 p17 HIV 2 Only Antibody BioRad New LAV HIV-II gp140 gp105 p68 p56 gp36 p34 p26 p16 MP Biomedicals -Blot gp125 gp80 p68 p56 p53 gp36 p26 RS17-HIV Page 4 of 5

5 Interpretative Comment For the purposes of data management, please use the comments provided. It is acceptable to tick more than one comment per specimen. Interpretative Comment for HIV A B 1 No evidence of HIV 1/2 infection, suggest repeat testing if clinically indicated 2 No evidence of HIV 1/2 infection, HIV p24 Ag testing should be performed if the individual is suspected to be at risk of acute HIV infection or have seroconversion illness 3 Refer for HIV Ag testing and subsequent neutralisation testing as required 4 Refer for HIV Ab confirmatory immunoblot testing Serology is consistent with acute HIV infection, please send another serum sample to confirm result Serology is consistent with HIV infection, please send another serum sample to confirm result Serology results are inconclusive, please send another serum sample for repeat testing 8 Perform HIV Ab or HIV Ag/Ab combination screening testing 9 Refer for HIV-2 Ab supplementary and/or confirmatory immunoblot testing 10 Refer for HIV nucleic acid testing 11 Send to HIV Reference Laboratory 12 Serology is consistent with HIV-2 infection, please send another serum sample to confirm result 13 No comment or Not tested RS17-HIV Page 5 of 5

HIV Serology Quality Assessment Program Summary for Panel HIVS Oct22

HIV Serology Quality Assessment Program Summary for Panel HIVS Oct22 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary

More information

NEW CHALLENGES FOR ACCURATE HIV-1 DIAGNOSIS ALL BELGIAN AIDS REFERENCE LABORATORIES KAROLIEN STOFFELS (ARL VUB STP) & FIEN VANROYE (ARL ITM)

NEW CHALLENGES FOR ACCURATE HIV-1 DIAGNOSIS ALL BELGIAN AIDS REFERENCE LABORATORIES KAROLIEN STOFFELS (ARL VUB STP) & FIEN VANROYE (ARL ITM) NEW CHALLENGES FOR ACCURATE HIV-1 DIAGNOSIS ALL BELGIAN AIDS REFERENCE LABORATORIES KAROLIEN STOFFELS (ARL VUB STP) & FIEN VANROYE (ARL ITM) 30 NOVEMBER 2018, BRUGGE 0 NEW CHALLENGES FOR ACCURATE HIV-1

More information

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary

More information

AccuSet HIV-1/2 Performance Panel

AccuSet HIV-1/2 Performance Panel OVERVIEW AccuSet HIV-1/2 (0800-0380) is a 13-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members represent bleeds from multiple

More information

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2018Apr19

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2018Apr19 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary

More information

HIV Serology Quality Assessment Program Revised Summary for Panel HIVSER 2017Oct27

HIV Serology Quality Assessment Program Revised Summary for Panel HIVSER 2017Oct27 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Revised

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Peters PJ, Westheimer E, Cohen S, et al. Screening yield of HIV antigen/antibody combination and pooled HIV RNA testing for acute HIV infection in a high-prevalence population.

More information

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

AccuSet Anti-HIV-1 Mixed Titer Performance Panel signal to cut-off (s/co) DATA SHEET OVERVIEW PRB205(M3) is a modified 16-member panel originating from Anti- HIV-1 Mixed Titer PRB205(M2). Panel members 3, 5, 6, 17, 21, 22, 23, 24, and 25 from the original

More information

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016 New HIV Testing Algorithm from CDC ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Learning Objectives Following attendance and review of material provided, attendees will be able to: 1. Describe the new

More information

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons

More information

Technical Bulletin No. 104b

Technical Bulletin No. 104b CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 104b June 22, 2016 Update to Guidelines for Diagnosing HIV Infection CPAL s Testing Algorithm for Diagnostic HIV Testing HIV Geenius

More information

Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc)

Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) Date: 6 January 2012 Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) WHO Collaborating Centre for HIV/AIDS Diagnostic and Laboratory Support Department of Clinical Sciences

More information

AccuSet HCV Performance Panel

AccuSet HCV Performance Panel Signal to cutoff (s/co) DATA SHEET OVERVIEW AccuSet HCV (0810-0204) is a 25-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members

More information

HIV-1 Seroconversion Panel

HIV-1 Seroconversion Panel OVERVIEW This Data Sheet contains test results specific for HIV-1. s are undiluted aliquots from plasma units collected from a single donor. No preservatives were added. CAUTION: Potentially infectious

More information

HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2017Apr19

HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2017Apr19 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2017Apr19

More information

True Status A B. HTLV I Positive. Indeterminate. HTLV I/II Negative HV15 HV16 HV18 HV21 HV22 HV44 HV55. Selected Legend: Flagged: Unresolved

True Status A B. HTLV I Positive. Indeterminate. HTLV I/II Negative HV15 HV16 HV18 HV21 HV22 HV44 HV55. Selected Legend: Flagged: Unresolved National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 206Apr2 Panel

More information

HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2016Oct28

HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2016Oct28 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2016Oct28

More information

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

AccuSet Anti-HIV-1 Mixed Titer Performance Panel PACKAGE INSERT PRB205(M3) / (0800-0379) INTENDED USE The Performance Panel PRB205(M3) / (0800-0379) is intended for use by diagnostics manufacturers and clinical laboratorians to evaluate their HIV-1 test

More information

Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed

Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed Seroconversion OVERVIEW HIV-1 AccuVert TM Seroconversion PRB970 is a 4 member, 1.0 ml per vial panel of undiluted, naturally-occurring plasma samples. members represent serial bleeds collected from a single

More information

HIV-1 Seroconversion Panel PRB975

HIV-1 Seroconversion Panel PRB975 Seroconversion OVERVIEW is a five member HIV Seroconversion collected from a single donor over a 14 day period in 2002, prior to antibody seroconversion. -03 is a challenging sample for HIV RNA assays,

More information

Adventures in Discordance- HIV Testing

Adventures in Discordance- HIV Testing Anne Gaynor, PhD On behalf of Monica M. Parker, PhD Director, Bloodborne Viruses Laboratory Wadsworth Center, NYSDOH Adventures in Discordance- HIV Testing HIV Laboratory Testing Algorithm HIV-1/2 antigen/antibody

More information

HIV-1 Seroconversion Panel

HIV-1 Seroconversion Panel A SERACARE PANEL PRODUCT Seroconversion INTENDED USE The Seroconversion is a group of serial bleeds from an individual plasma donor during seroconversion. This is intended for use by diagnostics manufacturers

More information

WHO PROTOCOL FOR PERFORMANCE LABORATORY EVALUATION OF HIV SEROLOGY ASSAYS

WHO PROTOCOL FOR PERFORMANCE LABORATORY EVALUATION OF HIV SEROLOGY ASSAYS WHO PROTOCOL FOR PERFORMANCE LABORATORY EVALUATION OF HIV SEROLOGY ASSAYS WHO/EMP/RHT/PQT/2017.xx Page 1 of 17 World Health Organization 2017 Some rights reserved. This work is available under the Creative

More information

Performance of the HIV Blot 2.2, INNO-LIA HIV I/II Score, and Geenius HIV 1/2 Confirmatory Assay for use in HIV confirmation

Performance of the HIV Blot 2.2, INNO-LIA HIV I/II Score, and Geenius HIV 1/2 Confirmatory Assay for use in HIV confirmation RESEARCH ARTICLE Performance of the HIV Blot 2.2, INNO-LIA HIV I/II Score, and Geenius HIV 1/2 Confirmatory Assay for use in HIV confirmation Chui Ching Wong 1, Siew Hoon Lim 1, Chai Teng Tan 1, Sook Yin

More information

Prequalification of In Vitro Diagnostics. WHO PROTOCOL for laboratory evaluation of Combined HIV/Syphilis serology assays. PQDx_150. Version: 4.

Prequalification of In Vitro Diagnostics. WHO PROTOCOL for laboratory evaluation of Combined HIV/Syphilis serology assays. PQDx_150. Version: 4. SOP_ WHO PROTOCOL FOR THE LABORATORY EVALUATION OF COMBINED HIV/SYPHILIS SEROLOGY ASSAYS Prequalification-In vitro Diagnostics Assessment Prequalification of In Vitro Diagnostics WHO PROTOCOL for laboratory

More information

Using all the data: Immunoassay signal-to-cutoff values provide useful information that should be considered in HIV diagnostic

Using all the data: Immunoassay signal-to-cutoff values provide useful information that should be considered in HIV diagnostic Using all the data: Immunoassay signal-to-cutoff values provide useful information that should be considered in HIV diagnostic algorithms KP Delaney, M Pentella, B Bennett, and K Landgraf for the CDC/APHL

More information

HIV-1 Seroconversion Panel PRB973

HIV-1 Seroconversion Panel PRB973 A SERACARE PANEL PRODUCT INTENDED USE The is a group of serial bleeds from an individual plasma donor during seroconversion. This panel is intended for use by diagnostics manufacturers and clinical laboratorians

More information

Diagnostic Tests for HIV

Diagnostic Tests for HIV Mountain West AIDS Education and Training Center Diagnostic Tests for HIV David Spach, MD Principal Investigator, Mountain West AETC Professor of Medicine, University of Washington Last Updated: June 22,

More information

AccuVert HIV-1 Seroconversion Panel PRB974 ( )

AccuVert HIV-1 Seroconversion Panel PRB974 ( ) PACKAGE INSERT PRB974 (0600-0258) INTENDED USE PRB974 (0600-0258) is a group of serial bleeds from an individual plasma donor during seroconversion. This panel is intended for use by diagnostics manufacturers

More information

detection of HIV-1/2 antibodies

detection of HIV-1/2 antibodies CVI Accepts, published online ahead of print on 18 June 214 Clin. Vaccine Immunol. doi:1.1128/cvi.153-14 Copyright 214, American Society for Microbiology. All Rights Reserved. 1 2 Evaluation of Bio-Rad

More information

HIV-2 Infection in Malaysia: Current situation and the use of in-house real-time reverse transcription PCR for HIV-2

HIV-2 Infection in Malaysia: Current situation and the use of in-house real-time reverse transcription PCR for HIV-2 Tropical Biomedicine 35(3): 769 774 (2018) HIV-2 Infection in Malaysia: Current situation and the use of in-house real-time reverse transcription PCR for HIV-2 Mohd Zain, R. 1, Ismail, S. 1, Ellan, E.K.

More information

HTLV Serology Quality Assessment Program Summary for Panel HTLS Oct22

HTLV Serology Quality Assessment Program Summary for Panel HTLS Oct22 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLS425 2015Oct22

More information

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC) HIV Update in Laboratory Testing Patricia Slev, PhD, D(ABCC) Objectives Explain the advances in HIV diagnostics, including fourth generation Ag/Ab combination HIV screening assays Describe the new CDC

More information

HOPE Follow-Up Algorithm: Unusual Cases. Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town

HOPE Follow-Up Algorithm: Unusual Cases. Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town HOPE Follow-Up Algorithm: Unusual Cases Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town MTN-025 Testing Algorithm Screening/Enrollment MTN-025 Testing Algorithm

More information

HIV ASSAYS: OPERATIONAL CHARACTERISTICS REPORT 16 RAPID ASSAYS

HIV ASSAYS: OPERATIONAL CHARACTERISTICS REPORT 16 RAPID ASSAYS HIV ASSAYS: OPERATIONAL CHARACTERISTICS REPORT 6 RAPID ASSAYS HIV ASSAYS: OPERATIONAL CHARACTERISTICS REPORT 6 RAPID ASSAYS WHO Library CataloguinginPublication Data HIV antigen/antibody assays : operational

More information

Maximizing Cornea and Tissue Donation through Specimen Quality

Maximizing Cornea and Tissue Donation through Specimen Quality Maximizing Cornea and Tissue Donation through Specimen Quality Robert W. Bresler, Sydney D. Gastreich, Elias G. Koulouriotis, Linda S. Martin, Susan Diane Brockmeier, Chak-Sum Ho, PhD Abstract Purpose:

More information

List of HIV diagnostics eligible to tender for procurement by WHO in 2011

List of HIV diagnostics eligible to tender for procurement by WHO in 2011 Since 1988, WHO has performed assessments of commercially available diagnostics for HIV, hepatitis B, hepatitis C and Chagas disease. Up to 2006, this process was called the WHO Test Kit Evaluation programme,

More information

Research Article Decision on conducting HCV Immunoblot and HCV Viral Load Tests Dependent upon the Result of the Screening Tests

Research Article Decision on conducting HCV Immunoblot and HCV Viral Load Tests Dependent upon the Result of the Screening Tests IBIMA Publishing Journal of Virology & Microbiology http://www.ibimapublishing.com/journals/jvm/jvm.html Vol. 2013 (2013), Article ID 332501, 7 pages DOI: 10.5171/2013.332501 Research Article Decision

More information

HIV-1 Seroconversion Panel PRB964

HIV-1 Seroconversion Panel PRB964 A SERACARE PANEL PRODUCT Seroconversion INTENDED USE The is a group of serial bleeds from an individual plasma donor during seroconversion. This is intended for use by diagnostics manufacturers and clinical

More information

HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version

HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version 1 HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM Event Name: Event Time Period: ADULT HIV 900 (AIDS.gov 12/31/2015) HIV Lifelong HIV (human immunodeficiency virus) is a retrovirus

More information

Complicated viral infections

Complicated viral infections Complicated viral infections Clinical case discussion Diagnostic dilemmas NSW State Reference Laboratory for HIV St Vincent s Hospital Sydney Diagnostic dilemmas Indeterminate or discordant serology (western

More information

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests Ann Winters, MD Medical Director, Viral Hepatitis Program, Bureau of Communicable Disease, New York City Department of Health and Mental

More information

ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S.

ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S. ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S. Catherine Brennan, Ph.D. Research Fellow Infectious Diseases Research Abbott Diagnostics 1 Agenda ARCHITECT HIV Ag/Ab Combo Assay What

More information

Confirmatory Testing Algorithm. Routine Donor Testing Algorithm

Confirmatory Testing Algorithm. Routine Donor Testing Algorithm Confirmatory Testing Algorithm Blood Confirmatory ABO/Rh Beckman Coulter PK-ABO/Rh Immucor NEO ABO/Rh Immucor NEO ABO/Rh Immucor Manual ABO/Rh Typing Immucor Manual ABO/Rh Typing Discrepancy Resolution

More information

2018 HIV and HCV Diagnostic Testing Survey

2018 HIV and HCV Diagnostic Testing Survey 2018 HIV and HCV Diagnostic Testing Survey This survey is designed to capture the 2017 HIV and HCV testing practices in state and local public health laboratories (PHL). The results of the survey will

More information

AccuVert HIV-1 Seroconversion Panel PRB955 ( ) / Batch #

AccuVert HIV-1 Seroconversion Panel PRB955 ( ) / Batch # Signal to cutoff (s/co) Copies per ml (c/ml) OVERVIEW AccuVert is a 5-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members represent

More information

T pallidum. Table of contents

T pallidum. Table of contents An assessment of Point of Care Tests for Hepatitis B, Hepatitis C, HIV and Syphilis for use in an Operational Environment to Provide Emergency Transfusion Support Microbiological Diagnostics Assessment

More information

Parvovirus B19 Mixed Titer Performance Panel PVP201

Parvovirus B19 Mixed Titer Performance Panel PVP201 A SERACARE PANEL PRODUCT INTENDED USE The is a panel of naturally occurring plasma specimens. This panel is intended for use by diagnostic manufacturers and clinical laboratories to evaluate their Parvovirus

More information

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere HIV Combo WHO reference number: PQDx

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere HIV Combo WHO reference number: PQDx WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere HIV Combo WHO reference number: PQDx 0243-013-00 Alere HIV Combo with product codes 7D2842, 7D2843, 7D2843SET manufactured by Alere

More information

CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE

CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE TITLE : SOP for (off board dilution) Less Sensitive Modified VITROS Enzyme Immunoassay CEPHIA DOCUMENT

More information

SEROLOGICAL DIAGNOSIS OF VIRAL INFECTIONS:

SEROLOGICAL DIAGNOSIS OF VIRAL INFECTIONS: SEROLOGICAL DIAGNOSIS OF VIRAL INFECTIONS: POSSIBILITIES OF SEROLOGICAL DIAGNOSIS TYPES OF SEROLOGICAL REACTIONS SEROLOGICAL REACTIONS Ag-Ab reactions used for the detection of unknown Ag or Ab, in vitro

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319

More information

Clinical HIV-2 Viral Load Testing of a Large Population of HIV-2 Infected Individuals

Clinical HIV-2 Viral Load Testing of a Large Population of HIV-2 Infected Individuals Clinical HIV-2 Viral Load Testing of a Large Population of HIV-2 Infected Individuals Linda M. Styer Wadsworth Center, NYSDOH ** The authors have no conflicts of interest to disclose ** HIV-2 viral load

More information

HIV Testing Technology and the Latest Algorithm

HIV Testing Technology and the Latest Algorithm HIV Testing Technology and the Latest Algorithm David Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene HIV Testing has changed over time Patients with

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK West of Scotland Specialist Virology Centre New Lister Building Level 5 Glasgow Royal Infirmary 10-16 Alexandra Parade Glasgow G31 2ER Contact:

More information

New HIV Tests and Algorithm: A change we can believe in

New HIV Tests and Algorithm: A change we can believe in New HIV Tests and Algorithm: A change we can believe in Esther Babady, PhD, D (ABMM) Memorial Sloan-Kettering Cancer Center New York, New York Learning Objectives After this presentation you should be

More information

HIV-1 AccuVert TM Seroconversion Panel

HIV-1 AccuVert TM Seroconversion Panel PACKAGE INSERT PRB954 (0600-0238) INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot test methods. Characterized

More information

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention Evolution of HIV Diagnostics and Goals for the 2010 Conference Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics CDC Division of HIV/AIDS Prevention Evolution or other influences like

More information

AccuVert HBV Seroconversion Panel PHM941(M) ( )

AccuVert HBV Seroconversion Panel PHM941(M) ( ) PACKAGE INSERT PHM941(M) (0605-0061) INTENDED USE PHM941(M) (0605-0061) is a group of serial bleeds from an individual plasma donor during HBV seroconversion. This panel is intended for use by diagnostics

More information

The Challenges in Developing and Commercializing HIV Tests that are Useful in Differentiating VISP/R VISP/R Workshop Bethesda, MD March 2013

The Challenges in Developing and Commercializing HIV Tests that are Useful in Differentiating VISP/R VISP/R Workshop Bethesda, MD March 2013 The Challenges in Developing and Commercializing HIV Tests that are Useful in Differentiating VISP/R VISP/R Workshop Bethesda, MD March 2013 Christopher Bentsen, M.S.,RAC, FRAPS Bio-Rad Laboratories, Redmond,

More information

FINAL REPORT HBV Serology External Quality Assessment Scheme

FINAL REPORT HBV Serology External Quality Assessment Scheme FINAL REPORT HBV Serology External Quality Assessment Scheme Programme codes: HBVC4310, HBVC435 Panel ID: 2008/Mar/11 HBV Serology EQAS Panel ID 2008/Mar/11 Page 1 of 9 The NRL is a: NATA-accredited proficiency

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Murex HIV Ag/Ab Combination Number: PQDx

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Murex HIV Ag/Ab Combination Number: PQDx WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Murex HIV Ag/Ab Combination Number: PQDx 0144-043-00 Abstract Murex HIV Ag/Ab Combination with product codes 7G79-09 (GE41,

More information

FINAL REPORT HBV Serology External Quality Assessment Scheme

FINAL REPORT HBV Serology External Quality Assessment Scheme FINAL REPORT HBV Serology External Quality Assessment Scheme Programme codes: HBVC4310, HBVC435 Panel ID: 2008/Oct/28 HBV Serology EQAS Panel ID 2008/Oct/28 Page 1 of 11 The NRL is a: NATA-accredited proficiency

More information

Mom Chandara, Msc, NIPH Team

Mom Chandara, Msc, NIPH Team Mom Chandara, Msc, NIPH Team EXTERNAL QUALITY ASSESSMENTS (EQAS) EQA refers to a system in which laboratory results are scrutinized objectively by an outside agency in order to get a general impression

More information

Original Article HIV Indeterminate Western Blot Results in Blood Donors in Northeast of Iran,

Original Article HIV Indeterminate Western Blot Results in Blood Donors in Northeast of Iran, Iranian Journal of Virology 2014;8(1): 1-6 2014, Iranian Society of Virology Original Article HIV Indeterminate Western Blot Results in Blood Donors in Northeast of Iran, 2009-2014 Shams SF 1*, Arianpour

More information

Hepatitis C January 26, 2018

Hepatitis C January 26, 2018 Hepatitis C January 26, 2018 Case Investigation Guidelines Contents A. Purpose...2 B. Case Definitions...2 a. Acute Hepatitis C (2016...2 b. Chronic Hepatitis C (2016)...3 c. Perinatal Hepatitis C (2017

More information

HIV Diagnostic Testing

HIV Diagnostic Testing In The name of God HIV Diagnostic Testing By : Dr. Shahzamani PhD of Medical virology Purpose of HIV Testing To identify asymptomatic individuals To diagnose HIV infection in those who practice high risk

More information

INTERPRETING HEPATITIS B SEROLOGY

INTERPRETING HEPATITIS B SEROLOGY INTERPRETING HEPATITIS B SEROLOGY RECOMMENDED WORDING FOR NATIONAL LABORATORIES TO REPORT HEPATITIS B DIAGNOSTIC TEST RESULTS THIS DOCUMENT HAS BEEN ENDORSED BY: Australasian Society for HIV Medicine,

More information

Original Article Evaluation of HIV Indeterminate Confirmatory Test Results of Blood Donors in Northeast of Iran

Original Article Evaluation of HIV Indeterminate Confirmatory Test Results of Blood Donors in Northeast of Iran International Journal of Medical Laboratory 2015;2(1):58-64. Original Article Evaluation of HIV Indeterminate Confirmatory Test Results of Blood Donors in Northeast of Iran Seyyede Fatemeh Shams 1* M.Sc.,

More information

WHO Prequalification of Diagnostics Programme PUBLIC REPORT

WHO Prequalification of Diagnostics Programme PUBLIC REPORT WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: ABON HIV 1/2/O Tri-Line Human Immunodeficiency Virus Rapid Test Device Number: PQDx 0141-051-00 Abstract ABON HIV 1/2/O Tri-Line Human

More information

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance Infectious Disease Testing ULTRA Product Line Safety is not a Matter of Chance ULTRA Product Line The best answer for HBV, HCV and HIV screening: a global automated solution for safe results. Monolisa

More information

4.5. How to test - testing strategy HBV Decision-making tables PICO 3

4.5. How to test - testing strategy HBV Decision-making tables PICO 3 World Health Organization Global Hepatitis Programme 4.5. How to test - testing strategy HBV Decision-making tables PICO 3 Testing strategy to diagnose chronic HBV infection through detection of HBsAg:

More information

HIV testing has significantly improved

HIV testing has significantly improved HIV testing: an update By Nicola Zetola, MD, and Jeffrey D. Klausner, MD, MPH HIV testing has significantly improved since the first diagnostic test in 1985. Increased understanding of HIV transmission

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Enzygnost HIV Integral 4 WHO reference number: PQDx

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Enzygnost HIV Integral 4 WHO reference number: PQDx PQDx 0214-064-00 WHO PQDx PR April/2016, version 3.0 WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Enzygnost HIV Integral 4 WHO reference number: PQDx 0214-064-00 Enzygnost

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Bioelisa HIV 1+2 Ag/Ab Number: PQDx

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Bioelisa HIV 1+2 Ag/Ab Number: PQDx WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Bioelisa HIV 1+2 Ag/Ab Number: PQDx 0183-060-00 Abstract Bioelisa HIV 1+2 Ag/Ab with product codes 3000-1172 and 300-1173,

More information

TEST REQUEST INFORMATION- VIROLOGY

TEST REQUEST INFORMATION- VIROLOGY Chlamydia/ Gonorrhea Nucleic Acid Amplification VC75 Qualitative Nucleic Acid Amplification SPECIMEN: Genital swab or first catch urine CONTAINER:GEN-PROBE APTIMA 2 Combo swab transport tube or urine transport

More information

Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.

Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T. Blood Screening Assays CTS lab locations where assays are performed are indicated by alpha codes D, P, and T. D= performed in Dallas lab FEI: 3002580251 P= performed in Phoenix lab FEI: 3000204058 T= performed

More information

Trends in molecular diagnostics

Trends in molecular diagnostics Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling

More information

An Evaluation of Qualitative HIV-2 RNA Referral Testing

An Evaluation of Qualitative HIV-2 RNA Referral Testing An Evaluation of Qualitative HIV-2 RNA Referral Testing Linda M. Styer, Anne Gaynor, Laura Wesolowski, Steve Ethridge and Monica M. Parker Wadsworth Center, NYSDOH; APHL; Division of HIV/AIDS Prevention,

More information

HIV testing technologies

HIV testing technologies HIV testing technologies HIV testing technologies are used to determine if a person has HIV. Several types of HIV testing technologies are used in Canada. These tests differ in several ways, including

More information

Equine Infectious Anemia

Equine Infectious Anemia Equine Infectious Anemia CJ Issel, DVM, PhD University of Kentucky Gluck Equine Research Center Typical Clinical Course of EIAV Infections Acute Chronic Inapparent 42 10 9 10 8 41 200 Viral RNA log 10

More information

Predicting Human Immunodeficiency Virus Type 1-Positive Sera by

Predicting Human Immunodeficiency Virus Type 1-Positive Sera by JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1991, p. 2507-2512 0095-1137/91/112507-06$02.00/0 Copyright 1991, American Society for Microbiology Vol. 29, No. 11 Predicting Human Immunodeficiency Virus Type 1-Positive

More information

1 st and 2 nd Generation EIA

1 st and 2 nd Generation EIA HIV Diagnostic Tests Bernard M. Branson, M.D. Associate D irector for Laboratory D iagnostics Division of HIV/AIDS Prevention Centers for D isease Control & Prevention The views expressed in this presentation

More information

Technical Bulletin No. 104a

Technical Bulletin No. 104a CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 104a April 22, 2014 Update to Guidelines for Diagnosing HIV Infection - CPAL s Testing Algorithm for Diagnostic HIV Testing Contact:

More information

Epidemiologists and Laboratory Science

Epidemiologists and Laboratory Science Epidemiologists and Laboratory Science Najib Aziz, M.D. Adjunct Associate Professor Department of Epidemiology UCLA, Fielding School of Public Health January 2014 Introduction: Advance in the laboratory

More information

How are testing technologies used to diagnose HIV infection?

How are testing technologies used to diagnose HIV infection? HIV testing technologies are used to determine if a person has HIV. Several types of HIV testing technologies are used in Canada. These tests differ in several ways, including where the test is conducted,

More information

HIV Guideline Sakchai Dettrairat

HIV Guideline Sakchai Dettrairat HIV Guideline 2016 Sakchai Dettrairat Division of Clinical Immunology Department of Medical Technology Faculty of Associated Medical Sciences Chiang Mai University Appearance of HIV markers in early HIV

More information

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma Test Name *Minimum Collection Tubes Sample Stability ABO/Rh Blood Typing 50 µl cells EDTA whole blood (lavender-top) Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

More information

VIDRL & WHO Measles IgM Proficiency Panel Final Report Prepared by Jennie Leydon, Michaela Riddell & Dr Mike Catton Director VIDRL

VIDRL & WHO Measles IgM Proficiency Panel Final Report Prepared by Jennie Leydon, Michaela Riddell & Dr Mike Catton Director VIDRL VIDRL & WHO Measles IgM Proficiency Panel 00702 Final Report Prepared by Jennie Leydon, Michaela Riddell & Dr Mike Catton Director VIDRL Table of Contents Tables and Figures... 3 Abbreviations... 4 Introduction...

More information

GeneXpert HIV-1 Quantitative assay Natasha Samsunder

GeneXpert HIV-1 Quantitative assay Natasha Samsunder GeneXpert HIV-1 Quantitative assay Natasha Samsunder CAPRISA INTRODUCTION Cepheid HIV-1 Quant Assay is an automated single cartridge-based quantitative nucleic acid amplification test that is designed

More information

2.1 HIV antibody tests

2.1 HIV antibody tests Over 100 different kinds of HIV test are currently available worldwide. More are likely to become available in the future. The choice of test depends on factors including laboratory requirements, how easy

More information

Comparison of the Geenius HIV-1/2 Supplemental Assay and HIV-1 Western blot for HIV rapid test confirmation from dried blood spots

Comparison of the Geenius HIV-1/2 Supplemental Assay and HIV-1 Western blot for HIV rapid test confirmation from dried blood spots Comparison of the Geenius HIV-1/2 Supplemental Assay and HIV-1 Western blot for HIV rapid test confirmation from dried blood spots Timothy J. Sullivan Bloodborne Viruses Laboratory Wadsworth Center, NYSDOH

More information

A Summary of Clinical Evidence

A Summary of Clinical Evidence A Summary of Clinical Evidence Supporting the use of the Alere Determine HIV-1/2 Ag/Ab Combo Rapid Test to assist in the diagnosis of Human Immunodeficiency Virus (HIV) TAP HERE TO SEE THE PRODUCTS Table

More information

J07 Titer dynamics, complement fixation test and neutralization tests

J07 Titer dynamics, complement fixation test and neutralization tests avllm0421c (spring 2017) J07 Titer dynamics, complement fixation test and neutralization tests Outline titer, antibody titer dynamics complement, complement fixation reaction neutralization tests 2/35

More information

UKNEQAS Toxoplasma Serology. It is the fault of the kits or is it?

UKNEQAS Toxoplasma Serology. It is the fault of the kits or is it? UKNEQAS Toxoplasma Serology It is the fault of the kits or is it? Purpose of the Schemes The Toxoplasma subschemes consist of IgG and IgM and are designed to: Provide information allowing participants

More information

Appendix B: Provincial Case Definitions for Reportable Diseases

Appendix B: Provincial Case Definitions for Reportable Diseases Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Hemorrhagic fevers caused by: i) Ebola virus and ii) Marburg virus and iii) Other viral causes including

More information

HIV: 2009 DIAGNOSTIC SURVEY FACING NEW CHALLENGES

HIV: 2009 DIAGNOSTIC SURVEY FACING NEW CHALLENGES ISSUES IN BRIEF: MEMBER SURVEY OF HIV ASSAY USE ASSOCIATION OF PUBLIC HEALTH LABORATORIES MARCH 2010 HIV: 2009 DIAGNOSTIC SURVEY FACING NEW CHALLENGES Twenty years ago, the Association of Public Health

More information

DHS COMPARATIVE REPORTS 39

DHS COMPARATIVE REPORTS 39 PERFORMANCE OF ENZYME IMMUNOASSAYS FOR HIV SEROLOGY IN SURVEYS CONDUCTED BY THE DEMOGRAPHIC AND HEALTH SURVEYS PROGRAM DHS COMPARATIVE REPORTS 39 March 2016 This publication was produced for review by

More information

Rubella Latex Agglutination Test

Rubella Latex Agglutination Test Rubella Latex Agglutination Test Cat. No.:DLAT1088 Pkg.Size:30T Intended use The Rubella Latex Agglutination Test is a rapid latex particle agglutination test for the qualitative and semi-quantitative

More information